Clinical Trial Update: A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FG-M108 in combination with chemotherapy versus placebo with chemotherapy for Claudin18.2-positive pancreatic cancer is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FG-M108 (FG-M108)

Snippet

Sponsor: FutureGen Biopharmaceutical (Beijing) Co., Ltd | Conditions: Pancreatic Cancer | Phase 3 | Status: NOT_YET_RECRUITING